Patent · US Active

Dithio ETP derivatives

US10822353B2 · kind B2 · utility

1Cited by

0References

34Claims

0Family size

Assignees

City of Hope · US
The Regents of the University of California · US

Inventors

Sangkil Nam · Duarte, US
David Horne · Duarte, US
Larry Eugene Overman · Newport Beach, US
Brad Loertscher · Portage, US

Key dates

Filing date	Sep 15, 2017
Grant date	Nov 3, 2020
Priority date	—
Expiry date	Sep 15, 2037

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein, inter alia, are compositions and methods of using the same for the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.